Armistice Capital, LLC 13D and 13G filings for Kura Oncology, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:45 pm Sale | 2025-09-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 4,672,000 5.370% | -1,900,000 (-28.91%) | Filing |
| 2025-11-14 6:20 pm Sale | 2025-09-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 3,277,272 4.080% | -1,458,192 (-30.79%) | Filing |
| 2025-08-14 9:42 pm Purchase | 2025-06-30 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 4,735,464 5.960% | 4,735,464 (New Position) | Filing |
| 2025-05-15 3:29 pm Purchase | 2025-03-31 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 6,572,000 7.590% | 772,000 (+13.31%) | Filing |
| 2025-02-14 5:30 pm Purchase | 2024-12-31 | 13G | Kura Oncology, Inc. KURA | Armistice Capital, LLC | 5,800,000 7.460% | 5,800,000 (New Position) | Filing |